Evidence map›Paper›PMID 37626166›Full record

ArticleScientific reports2023

Assessment of novel antiviral filter using pseudo-type SARS-CoV-2 virus in fast air velocity vertical-type wind tunnel.

Johnny Chun-Chau Sung, Pak-Long Wu, Ellis Yung-Mau So, Kam-Chau Wu, Sidney Man-Ngai Chan, Keith Wai-Yeung Kwong, Eric Tung-Po Sze

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Johnny Chun-Chau SungResearch Department, DreamTec Cytokines Limited, Hong Kong, China.
Pak-Long WuSchool of Science and Technology, Hong Kong Metropolitan University, Hong Kong, China.
Ellis Yung-Mau SoSchool of Science and Technology, Hong Kong Metropolitan University, Hong Kong, China.
Kam-Chau WuResearch Department, DreamTec Cytokines Limited, Hong Kong, China.
Sidney Man-Ngai ChanSchool of Science and Technology, Hong Kong Metropolitan University, Hong Kong, China.
Keith Wai-Yeung KwongResearch Department, DreamTec Cytokines Limited, Hong Kong, China.
Eric Tung-Po SzeSchool of Science and Technology, Hong Kong Metropolitan University, Hong Kong, China. esze@hkmu.edu.hk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current evidence suggests that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can remain suspended spread in aerosols for longer period of time under poorly ventilated indoor setting. To minimize spreading, application of antiviral filter to capture infectious aerosols and to inactivate SARS-CoV-2 can be a promising solution. This study aimed to develop a method to assess simultaneously the filtration and removal efficiency of aerosolized pseudo-type SARS-CoV-2 using a vertical-type wind tunnel with relatively high face velocity (1.3 m/s). Comparing with the untreated spunlace non-woven filter, the C-POLAR™ treated filter increased the filtration efficiency from 74.2 ± 11.5% to 97.2 ± 1.7%, with the removal efficiency of 99.4 ± 0.051%. The results provided not only solid evidence to support the effectiveness of the cationic polymeric coated filter in fighting against the SARS-CoV-2 pandemic, but also a method to test viral filtration and removal efficiency under relative fast air velocity and with a safer environment to the operators.

Indexed as

COVID-19Antiviral AgentsFiltrationHumansPandemicsSARS-CoV-2Antiviral Agents

Identifiers

PMID37626166
PMCPMC10457382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.